Notification and Disclosure. Obagi Inc. shall promptly notify the OMP Entities in writing of the existence and nature of, and shall promptly and fully disclose to the OMP Entities, any and all ideas, designs, practices, processes, apparatus, improvements, new product developments and inventions, proposed to be created or developed by Obagi Inc. pursuant to the new products development services described in Section 1(c)(1) or otherwise that Obagi Inc. has conceived or first actually reduced to practice and/or may conceive or first actually reduce to practice during the Term, including but not limited to those products listed in Exhibit D, or which Obagi Inc. may conceive or reduce to practice (all of which are hereinafter referred to as “Inventions”), within six months after the Term, if such Inventions relate to a product or process upon which Obagi Inc. worked during the Term or during the period of Dr. Obagi’s employment with OMP.
Appears in 2 contracts
Sources: Marketing Agreement (Obagi Medical Products, Inc.), Marketing Agreement (Obagi Medical Products, Inc.)